Maryland Heights, MO, March 08, 2017 --(PR.com
)-- The global immunoassay instruments market to reach nearly USD 20.5 Billion in 2020, at a CAGR of 6.4% from 2016 to 2020, due to higher incidence of chronic infections worldwide.
Browse Immunoassay Instruments Market by Instrument Type (Chemiluminescence Analyzers, Enzyme Immunoassay Instruments, Enzyme Linked Fluorescent Systems, Immunofluorescence Analyzers, Multiplexed Assay Systems, Radioimmunoassay Analyzers) and Applications (Autoimmune Diseases, Cardiology, Drugs of Abuse, Endocrinology, Infectious Diseases, Oncology, and Therapeutic Drug Monitoring) 2016-2020 at https://www.ihealthcareanalyst.com/report/immunoassay-instruments-market/
The immunoassay instruments are used in hospital and clinical laboratories to run automated biochemical tests to detect the presence and concentration of substances in the clinical samples. Immunoassay analyzers or instruments are bioanalytical devices that perform biochemical tests to detect or measure specific protein or other substances depending upon the reaction of an antigen (analyte) and an antibody. There are many types of tests that immunoassay analyzers can perform, including testing for cancer markers, diagnosing infectious diseases, cardiac analysis, therapeutic drug monitoring, and allergy testing. Immunoassay tests now a day exploring new avenues of applications in diagnosing infectious diseases, toxicology testing, detection of cancer biomarkers and other drug monitoring tests. Immunoassay techniques are especially suited for analyzing compounds that are present in extremely low concentration (nanogram to picogram) and without any prior treatments to enhance its detection. The several kinds of immunoassays are based on: chemiluminescence, enzyme immunoassay, enzyme-linked Fluorescence, immunofluorescence, multiplexed assays and radioimmunoassay.
The global immunoassay instruments market report estimates the market size (Revenue USD million - 2013 to 2020) and composition of this market and also forecasts growth trends (CAGR% - 2016 to 2020). The global immunoassay instruments market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global immunoassay instruments market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.
Major players operating in the global immunoassay instruments market and included in this report are Abbott Laboratories, bioMerieux, DiaSorin S.p.A, Siemens Healthcare, Roche Diagnostics, Thermo Fisher Scientific, Inc., and others.
To request Table of Contents and Sample Pages of this report visit:
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043